Neutropenia

Disease1 paper

Humans1

Trial sponsors

Amgen
Company1 trialPhase 2
Medical Research Council
1 trialPhase 32,000 people
Carelon Research
1 trialPhase 3114 people
Al-Azhar University
1 trialPhase 350 people
National Cancer Institute
1 trialPhase 2130 people
University of Nebraska
1 trialPhase 260 people
SWOG Cancer Research Network
1 trialPhase 250 people

Latest

2

HaematologicaHumans1 Oct

The role of CHIP and pre-treatment neutropenia in patients treated with chimeric antigen receptor T cells for hematological malignancies

Blood and immune system

HGG AdvancesHumans5 Sep

Inherited predisposition to increased systemic inflammation predicts a broad class of disease phenotypes